2016, Number 3
<< Back Next >>
Revista Cubana de Salud Pública 2016; 42 (3)
Impact of essential blood hypertension and ischemic heart diseases in sudden cardiac death victims
Vilches IE, Ochoa MLA, González LM, Ramos ML, Tamayo VND, García OD, Díaz LH
Language: Spanish
References: 21
Page: 432-441
PDF size: 145.94 Kb.
ABSTRACT
Objective: To determine the relationship between essential blood hypertension and
ischemic heart disease in sudden cardiac death.
Methods: Non-paired case-control observational analytical study of 600 natural
cardiac death cases which were diagnosed at “Julio Trigo Lopez” hospital in the
period of 2007 to 2011. In this group, 200 died from sudden cardiac death and 400
from non-sudden cardiac death; anatomic and pathological studies were performed.
Results: The univariate and multivariate analyses proved that blood hypertension
and ischemic heart disease were positively associated as risk factors for sudden
cardiac death. It was conformed that atherosclerotic lesions were significantly
present in sudden cardiac death victims together with these risk factors, so an
evident causality relationship was set. It was defined that anatomic pathological
studies exhibited higher level of reliability as to evaluation of a very controversial
issue such as sudden cardiac death.
Conclusions: Blood hypertension and ischemic heart disease are independent risk
factors for sudden cardiac death; both elements have direct marked relation with
the presence of atherosclerotic lesions in the coronary vascular tree as evidence of
the role of atherosclerosis in the etiopathogeny of the disease.
REFERENCES
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 201;380(9859):2224-60.
Chugh SS, Reinier K, Teodorescu C, Evanado A, Kehr E, Al Samara M, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51(3):213-28.
Bayés de Luna A, Elosua R. Muerte súbita. Rev Esp Cardiol. 2012;65(11):1039-52.
Ochoa Montes LA. Muerte súbita cardíaca. Estudio en comunidades de Arroyo Naranjo en el período 2000-2010 [tesis]. La Habana: Centro de Investigaciones y Referencias de Aterosclerosis de La Habana (CIRAH); 2012.
Morentin B, Audicana A. Estudio poblacional de la muerte súbita cardiovascular extrahospitalaria: incidencia y causas de muerte en adultos de edad mediana. Rev Esp Cardiol. 2011;64(1):28-34.
Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden Cardiac Death in the United States, 1989 to 1998. Circulation. 2001;104(18):2.158-63.
Muratore C, Belziti C, Gant López J, Di Toro D, Mulassi A, Corte M, et al. Incidencia y variables asociadas con la muerte súbita en una población general. Subanálisis del estudio PRISMA. Rev Argent Cardiol. 2006;74(6):441-6.
Kannel WB, McGee DL, Scharzkin A. An epidemiological perspective of sudden death: 26 years follow-up in the Framingham study. Drugs. 1984;28(supl I):1-5.
Castellá García J, Medallo Muñiz J, Marrón Moya T. Aspectos medicolegales de la muerte súbita cardiaca. Rev Esp Cardiol Supl. 2013;13(A):30-7.
Ochoa Montes LA, Tamayo Vicente ND, González Lugo M, Vilches Izquierdo E, Quispe Santos JF, Pernas Sánchez Y, et al. Resultados del Grupo de Investigación en Muerte Súbita, 20 años después de su creación. Rev Cubana Salud Pública. 2015 [citado 25 Mar 2016];41(2):298-323. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662015000200010&lng=es
Berton G, Cordiano R, Cavuto F, Giacomini G, De Toni R, Palatini P. Predictors of Ten-Year Event-Free Survival in Patients With Acute Myocardial Infarction. Italy Am Heart. 2011 [cited 2012 Feb 25];161(1):158-64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22221943
Cordero A, Lekuona I, Galve E, Mazón P. Novedades en hipertensión arterial y diabetes mellitus. Rev Esp Cardiol. 2012;65(Supl 1):12-23.
Kotseva K, Wood D, De BG, De BD, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929-40.
Bertomeu V, Cordero A, Quiles J, Mazón P, Aznar J, Bueno H. Control de los factores de riesgo y tratamiento de la cardiopatía isquémica: Registro TRECE (tratamiento de la Enfermedad Coronaria en España). Rev Esp Cardiol. 2009;62:807-11.
Tamayo Vicente ND, Ochoa Montes LA, Vilches Izquierdo E, González Lugo M, García Ones D. Infarto miocárdico crónico como factor de riesgo de muerte súbita cardíaca. Rev Cubana Invest Bioméd. 2015;34(2).
Warnes LA, Roberts WC. Sudden coronary death: Relation of amount and distribution of coronary narrowing at necropsy to previous symptoms of miocardial ischemia. Left ventricular scarring and heart weight. Am J Cardiol.1984;54(1):65- 72.
Hinkle LE, Thaler HT. Clinical in patients with acute ischemic heart disease classification of cardiac deaths. Circulation. 1982;3(6):457-64.
Marcus F, Leonard A. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event acute myocardial infarction. Am J Cardiol. 1988;61(1):8-15.
Fernández-Britto Rodríguez JE. La lesión aterosclerótica: estado del arte a las puertas del siglo xxI. Rev Cubana Invest Bioméd. 1998 [citada 27 May 2012];17(2):112-27. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S0864-030019980002 00002&lng=es
Mulè G, Nardi E, Cerasola G. Impact of Metabolic Syndrome on Left Ventricular Mass in Overweight and Obese Hypertensive Subjects. Intern J Cardiol. 2007;121(3):267-5.
Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation. 1996;93:2033-6.